• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏利什曼病死亡的预后因素及评分系统:巴西的一项历史性队列研究

Prognostic factors and scoring system for death from visceral leishmaniasis: an historical cohort study in Brazil.

作者信息

Coura-Vital Wendel, Araújo Valdelaine Etelvina Miranda de, Reis Ilka Afonso, Amancio Frederico Figueiredo, Reis Alexandre Barbosa, Carneiro Mariângela

机构信息

Pós-graduação em Ciências da Saúde, Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brasil; Núcleo de Pesquisas em Ciências Biológicas, Instituto de Ciências Exatas e Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brasil.

Secretaria Municipal de Saúde, Prefeitura de Belo Horizonte, Belo Horizonte, Minas Gerais, Brasil; Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brasil.

出版信息

PLoS Negl Trop Dis. 2014 Dec 11;8(12):e3374. doi: 10.1371/journal.pntd.0003374. eCollection 2014 Dec.

DOI:10.1371/journal.pntd.0003374
PMID:25503575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4263605/
Abstract

BACKGROUND

In Brazil, case-fatality rates attributable to visceral leishmaniasis (VL) are high and knowledge of the risk factors associated with death may help reduce mortality. The aim of this study was to construct and validate a scoring system for prognosis of death from VL by using all cases reported in Brazil from 2007 to 2011.

METHODOLOGY

In this historical cohort study, 18,501 VL cases were analyzed; of these, 17,345 cases were cured and 1,156 cases caused death. The database was divided into two series: primary (two-thirds of cases), to develop the model score, and secondary (one-third of cases), to validate the scoring system. Multivariate logistic regression models were performed to identify factors associated with death from VL, and these were included in the scoring system.

PRINCIPAL FINDINGS

The factors associated with death from VL were: bleeding (score 3); splenomegaly (score 1); edema (score 1); weakness (score 1); jaundice (score 1); Leishmania-HIV co-infection (score 1); bacterial infection (score 1); and age (≤0.5 years [score 5]; >0.5 and ≤1 [score 2]; >19 and ≤50 [score 2]; >50 and <65 [score 3]; ≥65 [score 5]). It was observed that patients with a score of 4 had a probability of death of approximately 4.5% and had a worse prognosis. The sensitivity, specificity, and accuracy of this score were 89.4, 51.2, and 53.5, respectively.

CONCLUSIONS/SIGNIFICANCE: The scoring system based on risk factors for death showed good performance in identifying patients with signs of severity at the time of clinical suspicion of VL and can contribute to improving the surveillance system for reducing case fatalities. The classification of patients according to their prognosis for death may assist decision-making regarding the transfer of the patients to hospitals more capable of handling their condition, admission to the intensive care unit, and adequate support and specific treatment.

摘要

背景

在巴西,内脏利什曼病(VL)的病死率很高,了解与死亡相关的危险因素可能有助于降低死亡率。本研究的目的是通过分析2007年至2011年巴西报告的所有VL病例,构建并验证一个VL死亡预后评分系统。

方法

在这项历史性队列研究中,分析了18501例VL病例;其中,17345例治愈,1156例死亡。数据库分为两个系列:主要系列(病例的三分之二)用于建立模型评分,次要系列(病例的三分之一)用于验证评分系统。采用多变量逻辑回归模型确定与VL死亡相关的因素,并将这些因素纳入评分系统。

主要发现

与VL死亡相关的因素有:出血(评分3);脾肿大(评分1);水肿(评分1);虚弱(评分1);黄疸(评分1);利什曼原虫与HIV合并感染(评分1);细菌感染(评分1);以及年龄(≤0.5岁[评分5];>0.5岁且≤1岁[评分2];>19岁且≤50岁[评分2];>50岁且<65岁[评分3];≥65岁[评分5])。观察到评分4的患者死亡概率约为4.5%,预后较差。该评分的敏感性、特异性和准确性分别为89.4、51.2和53.5。

结论/意义:基于死亡危险因素的评分系统在临床怀疑VL时识别有严重体征的患者方面表现良好,有助于改进监测系统以降低病死率。根据患者的死亡预后进行分类,可能有助于就将患者转至更有能力处理其病情的医院、入住重症监护病房以及给予适当支持和特定治疗等决策提供帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b0a/4263605/952c5cfb04b1/pntd.0003374.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b0a/4263605/c9d0734a4912/pntd.0003374.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b0a/4263605/bdced0285802/pntd.0003374.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b0a/4263605/952c5cfb04b1/pntd.0003374.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b0a/4263605/c9d0734a4912/pntd.0003374.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b0a/4263605/bdced0285802/pntd.0003374.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b0a/4263605/952c5cfb04b1/pntd.0003374.g003.jpg

相似文献

1
Prognostic factors and scoring system for death from visceral leishmaniasis: an historical cohort study in Brazil.内脏利什曼病死亡的预后因素及评分系统:巴西的一项历史性队列研究
PLoS Negl Trop Dis. 2014 Dec 11;8(12):e3374. doi: 10.1371/journal.pntd.0003374. eCollection 2014 Dec.
2
Prognostic factors for death from visceral leishmaniasis in patients treated with liposomal amphotericin B in an endemic state in Brazil.在巴西地方性流行状态下接受脂质体两性霉素B治疗的内脏利什曼病患者死亡的预后因素。
Trans R Soc Trop Med Hyg. 2017 Apr 1;111(4):163-171. doi: 10.1093/trstmh/trx029.
3
Early clinical manifestations associated with death from visceral leishmaniasis.内脏利什曼病死亡相关的早期临床症状。
PLoS Negl Trop Dis. 2012;6(2):e1511. doi: 10.1371/journal.pntd.0001511. Epub 2012 Feb 7.
4
Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.埃塞俄比亚一个艾滋病毒合并感染负担较高地区内脏利什曼病患者死亡临床预后评分的开发与外部验证
PLoS One. 2017 Jun 5;12(6):e0178996. doi: 10.1371/journal.pone.0178996. eCollection 2017.
5
A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan.南苏丹免疫功能正常患者内脏利什曼病的临床严重程度评分系统
PLoS Negl Trop Dis. 2017 Oct 2;11(10):e0005921. doi: 10.1371/journal.pntd.0005921. eCollection 2017 Oct.
6
Epidemiological patterns of mortality due to visceral leishmaniasis and HIV/AIDS co-infection in Brazil, 2000-2011.2000 - 2011年巴西内脏利什曼病与艾滋病毒/艾滋病合并感染所致死亡率的流行病学模式
Trans R Soc Trop Med Hyg. 2014 Jun;108(6):338-47. doi: 10.1093/trstmh/tru050. Epub 2014 Apr 4.
7
Visceral leishmaniasis in a Brazilian endemic area: an overview of occurrence, HIV coinfection and lethality.巴西一个地方病流行区的内脏利什曼病:发病情况、与艾滋病病毒合并感染及致死率概述
Rev Inst Med Trop Sao Paulo. 2018 Mar 8;60:e12. doi: 10.1590/S1678-9946201860012.
8
Risk factors for in-hospital mortality from visceral leishmaniasis: A case-control study.内脏利什曼病住院患者死亡的风险因素:一项病例对照研究。
J Infect Public Health. 2020 Apr;13(4):538-543. doi: 10.1016/j.jiph.2019.10.003. Epub 2019 Nov 11.
9
Risk Factors for Death from Visceral Leishmaniasis in an Urban Area of Brazil.巴西某城市地区内脏利什曼病死亡的危险因素
PLoS Negl Trop Dis. 2015 Aug 14;9(8):e0003982. doi: 10.1371/journal.pntd.0003982. eCollection 2015.
10
Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil.巴西特雷西纳内脏利什曼病死亡的预后因素。
Infection. 2003 Jun;31(3):174-7. doi: 10.1007/s15010-003-3139-9.

引用本文的文献

1
Spatial and temporal modeling of the global burden of Cutaneous Leishmaniasis in Brazil: A 21-year ecological study.巴西皮肤利什曼病全球负担的时空建模:一项 21 年的生态学研究。
PLoS Negl Trop Dis. 2024 Nov 20;18(11):e0012668. doi: 10.1371/journal.pntd.0012668. eCollection 2024 Nov.
2
T-cell and Soluble Co-inhibitory Receptor Expression in Patients With Visceral Leishmaniasis Are Markers of Treatment Response and Clinical Outcome.内脏利什曼病患者的T细胞和可溶性共抑制受体表达是治疗反应和临床结局的标志物。
Open Forum Infect Dis. 2024 Oct 30;11(11):ofae649. doi: 10.1093/ofid/ofae649. eCollection 2024 Nov.
3

本文引用的文献

1
Risk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysis.美国内脏利什曼病不良预后和死亡的危险因素:一项荟萃分析。
PLoS Negl Trop Dis. 2014 Jul 24;8(7):e2982. doi: 10.1371/journal.pntd.0002982. eCollection 2014 Jul.
2
Factors of poor prognosis of visceral leishmaniasis among children under 12 years of age. A retrospective monocentric study in Belo Horizonte, State of Minas Gerais, Brazil, 2001-2005.12 岁以下儿童内脏利什曼病预后不良的因素。巴西米纳斯吉拉斯州贝洛奥里藏特的一项回顾性单中心研究,2001-2005 年。
Rev Soc Bras Med Trop. 2013 Jan-Feb;46(1):55-9. doi: 10.1590/0037-868216432013.
3
MR1 blockade drives differential impact on integrative signatures based on circuits of circulating immune cells and soluble mediators in visceral leishmaniasis.
MR1 阻断基于循环免疫细胞和可溶性介质的电路对内脏利什曼病综合特征产生差异影响。
Front Immunol. 2024 Aug 13;15:1373498. doi: 10.3389/fimmu.2024.1373498. eCollection 2024.
4
The Parasitemia has Contributed to the Severity of Cases of Visceral Leishmaniasis.疟原虫血症导致了内脏利什曼病病例的严重程度。
Indian J Microbiol. 2024 Jun;64(2):511-519. doi: 10.1007/s12088-023-01182-6. Epub 2024 Jan 27.
5
Epidemiological and clinical trends of visceral leishmaniasis in Portugal: retrospective analysis of cases diagnosed in public hospitals between 2010 and 2020.葡萄牙内脏利什曼病的流行病学和临床趋势:2010 年至 2020 年期间在公立医院诊断的病例的回顾性分析。
Infect Dis Poverty. 2024 Jun 1;13(1):41. doi: 10.1186/s40249-024-01204-5.
6
High seroprevalence of Leishmania infantum is linked to immune activation in people with HIV: a two-stage cross-sectional study in Bahia, Brazil.婴儿利什曼原虫的高血清阳性率与HIV感染者的免疫激活有关:巴西巴伊亚州的一项两阶段横断面研究。
Front Microbiol. 2023 Jul 19;14:1221682. doi: 10.3389/fmicb.2023.1221682. eCollection 2023.
7
From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis.从感染到死亡:内脏利什曼病发病机制概述
Pathogens. 2023 Jul 24;12(7):969. doi: 10.3390/pathogens12070969.
8
Splenectomy for Visceral Leishmaniasis Out of an Endemic Region: A Case Report and Literature Review.脾脏切除术治疗内脏利什曼病:病例报告及文献复习。
Medicina (Kaunas). 2022 Jan 26;58(2):184. doi: 10.3390/medicina58020184.
9
A simple mortality risk prediction score for viper envenoming in India (VENOMS): A model development and validation study.印度蝰蛇咬伤简易死亡率风险预测评分(VENOMS):一项模型建立和验证研究。
PLoS Negl Trop Dis. 2022 Feb 22;16(2):e0010183. doi: 10.1371/journal.pntd.0010183. eCollection 2022 Feb.
10
Temporal Validation of a Predictive Score for Death in Children with Visceral Leishmaniasis.内脏利什曼病患儿死亡预测评分的时间验证
J Trop Med. 2021 Dec 22;2021:6688444. doi: 10.1155/2021/6688444. eCollection 2021.
Comparative analysis of pediatric and adult visceral leishmaniasis in Brazil.
巴西儿童与成人间内脏利什曼病的对比分析。
Pediatr Infect Dis J. 2013 May;32(5):e182-5. doi: 10.1097/INF.0b013e3182814eae.
4
American visceral leishmaniasis: factors associated with lethality in the state of são paulo, Brazil.美国内脏利什曼病:巴西圣保罗州与致死性相关的因素。
J Trop Med. 2012;2012:281572. doi: 10.1155/2012/281572. Epub 2012 Sep 13.
5
Leishmaniasis worldwide and global estimates of its incidence.全球利什曼病及其发病率的全球估计。
PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31.
6
Early clinical manifestations associated with death from visceral leishmaniasis.内脏利什曼病死亡相关的早期临床症状。
PLoS Negl Trop Dis. 2012;6(2):e1511. doi: 10.1371/journal.pntd.0001511. Epub 2012 Feb 7.
7
Prevalence and factors associated with Leishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methods.采用分子方法鉴定巴西城区犬感染利什曼原虫的流行情况及其相关因素。
PLoS Negl Trop Dis. 2011 Aug;5(8):e1291. doi: 10.1371/journal.pntd.0001291. Epub 2011 Aug 16.
8
Urban parasitology: visceral leishmaniasis in Brazil.城市寄生虫学:巴西内脏利什曼病。
Trends Parasitol. 2011 Sep;27(9):403-9. doi: 10.1016/j.pt.2011.04.001. Epub 2011 May 18.
9
Risk factors for death in children with visceral leishmaniasis.内脏利什曼病患儿死亡的危险因素。
PLoS Negl Trop Dis. 2010 Nov 2;4(11):e877. doi: 10.1371/journal.pntd.0000877.
10
Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study.严重内脏利什曼病是否是全身炎症反应综合征?一项病例对照研究。
Rev Soc Bras Med Trop. 2010 Jul-Aug;43(4):386-92. doi: 10.1590/s0037-86822010000400010.